Amp Ltd. Stock
Price
Target price
€0.97
€0.97
-2.020%
-0.02
-2.020%
-
30.10.25 / Stuttgart Stock Exchange
WKN: 914928 / Symbol: AMLTF / Name: AMP / Stock / Investment Banking & Investment Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Amp Ltd. Stock
We can see a decrease in the price for Amp Ltd.. Compared to yesterday it has lost -€0.020 (-2.020%).
Pros and Cons of Amp Ltd. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Amp Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Amp Ltd. | -2.020% | -2.020% | 5.435% | 14.793% | 3.191% | 22.013% | 10.227% |
| Australia and New Zealand Banking Group Ltd. | 0.460% | 3.543% | 14.001% | 12.177% | 22.840% | 27.315% | 85.277% |
| Commonwealth Bank Australia | 1.460% | 1.306% | 4.334% | 13.929% | 5.074% | 44.287% | 133.437% |
| Macquarie Group Ltd | -2.130% | -1.240% | 1.886% | -9.984% | -6.881% | 13.982% | 61.351% |
News
Elicio (ELTX) Q2 Loss Beats Estimates
Elicio Therapeutics (NASDAQ:ELTX), a biotechnology company focused on immunotherapies for cancer, reported its second quarter results on August 7, 2025, for the period ending June 30. The company
